Coloplast
| Industry:medical device | ISIN:DK0010309657 | Country:DK | CRR:B- |
Company Profile:
Coloplast‘s principal activities are the manufacturing and marketing of medical and health care products. The Company operates through five product segments: Ostomy Care, Continence Care, Wound Care, Skin Care and Breast Care.
Strengths/weaknesses profile:
Strengths:
- commitment to phase out phthalates
- systematic approach to incorporate product life cycle assessments in the development of new products
- reasonable measures to check compliance of key suppliers with the company's labour / health and safety standards
- implementation of a certified environmental management system at all major installations with significant environmental risks
- detailed ethical standards for clinical trials and the publication of their results
Weaknesses:
- lack of information regarding measures to reduce the environmental impact of transport
Reasons for inclusion in the Index:
Coloplast develops and markets medical products in the areas of ostomy care, wound care, urology and continence care, which are of growing significance, especially in an ageing society. The company is also actively involved in working to improve the health care structure in selected developing and newly industrialized countries, for example through specialist nurse training in stoma care. In recent years the company has greatly improved its transparency, and its particular strength is the breadth of its understanding of sustainability compared with other companies in the industry.